Tobacco settlement finance corporations are specialized entities that provide immediate capital to states and other parties entitled to payments from the Tobacco Master Settlement Agreement (MSA). The MSA, reached in 1998, was an agreement between the major US tobacco companies and 46 states, along with several territories and the District of Columbia, resolving lawsuits seeking to recover healthcare costs associated with tobacco-related illnesses. The agreement mandates ongoing payments from the tobacco companies to the settling parties in perpetuity. Because the annual payments from the MSA are predictable but unfold over decades, many states chose to securitize their future payments by selling them to tobacco settlement finance corporations. This allows states to access a lump sum of cash upfront, which can then be used for various purposes such as infrastructure projects, education funding, or balancing state budgets. These corporations operate by purchasing the rights to a stream of future tobacco settlement payments. They then issue bonds or other securities to investors, using the future tobacco payments as collateral to secure the debt. The investors receive a return on their investment from the ongoing payments made by the tobacco companies. The corporations profit from the difference between the price they pay for the rights to the tobacco settlement payments and the proceeds they receive from selling securities to investors. There are various forms of securitization. One common method involves creating a special purpose entity (SPE) that is bankruptcy-remote. This SPE purchases the rights to the tobacco payments and issues bonds. Because the SPE is legally separate from the state, even if the state were to face financial difficulties, the tobacco settlement payments dedicated to the SPE are protected and continue to flow to bondholders. The securitization of tobacco settlement payments has been controversial. While it provides states with immediate access to capital, it also means that they forgo future revenue streams. Some critics argue that states have underestimated the long-term value of the MSA payments and have sold them at a discount, effectively shortchanging future generations. Moreover, the long-term projections of tobacco sales, which underpin the value of the securities issued by tobacco settlement finance corporations, are subject to uncertainty. Declining smoking rates and potential future litigation against tobacco companies could impact the amount of payments received under the MSA, potentially affecting the ability of these corporations to meet their debt obligations. This introduces a level of risk for investors in these securities. Conversely, proponents argue that the immediate benefits of securitization outweigh the potential risks. States can use the upfront capital to address pressing needs or make strategic investments that generate greater returns than the forgone tobacco settlement payments. They also contend that sophisticated financial institutions have carefully analyzed the risks and rewards of securitization, and that states are making informed decisions based on their own unique circumstances and priorities. The activities of tobacco settlement finance corporations continue to be closely monitored by state governments, investors, and the public, as the ongoing health and financial implications of the MSA play out over time. The complex financial arrangements surrounding these payments underscore the tension between immediate needs and long-term financial planning, as states navigate the consequences of the historic settlement agreement.